Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP

Apollo Hospitals Enterprise — Q4 FY25 Earnings Presentation

42 slides from Apollo Hospitals Enterprise's earnings presentation, May 30, 2025

  1. Slide 1: Regulation 30 disclosure cover letter

    APOLLO HOSPITALS ENTERPRISE LIMITED CIN : L8511OTN1979PLC008035 •· A-'0110 ~OSPITALS 3Qth May 2025 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. Band

  2. Slide 2: Earnings Update Q4 FY25

    Apollo Hospitals Enterprise Limited • Earnings Update Q4 FY25

  3. Slide 3: Disclaimer

    Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor an

  4. Slide 4: Content

    Content Financial Performance Snapshot & Business Digital Health Segment wise Update & Pharmacy Distribution 4-9 (Apollo HealthCo) Consolidated Financials 11-12 Healthcare Services 14-23 Diagnostics & Retail Health (AHLL) 25-28 Digital Health & Pharmacy Distribution (Apollo HealthCo) 30-37 Annexure

  5. Slide 5: Financial Performance Snapshot Q4FY25

    Financial Performance Snapshot Q4FY25 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) Margin YoY(%) PAT YoY(%) 16% Healthcare Services 24.3% 13.6% 37% 28,219 10% 6,862 3,851 Offline PD ^ 20,844 17% 1,616 7.8% 21% Apollo HealthCo Online PD^ & 2,919 22% (1,253) Vs (1,219) in Q4F24 2

  6. Slide 6: Financial Performance Snapshot FY25

    Financial Performance Snapshot FY25 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) Margin YoY(%) PAT YoY(%) Healthcare Services 111,475 13% 27,005 24.2% 15% 14,260 12.8% 25% Offline PD ^ 80,143 16% 6,124 7.6% 17% Apollo HealthCo Online PD^ & (4,449) 10,787 20% Vs (6,047) in FY24

  7. Slide 7: Largest Pan India Hospital Chain

    Largest Pan India Hospital Chain Capacity Operational Hospitals Census Beds1 Census Beds Overall Total 73 10,187 9,458 Delhi: 5 Amritsar: 1 Noida: 1 Owned Hospitals 45 8,754 8,025 Bilaspur: 1 Kanpur: 1 Lucknow: 1 Indirapuram: 1 Managed Hospitals 6 790 790 Jaipur: 1 Day Surgery & 22 643 643 Cradle (A

  8. Slide 8: AHLL: Transforming Retail Health through access and convenience

    AHLL: Transforming Retail Health through access and convenience Apollo Health & Lifestyle Ltd Out-of-Hospital care • Outpatient Clinics • Diagnostics • Day Surgery centers • Single Specialty Facilities :- Dialysis, Sugar and Dental ,. Apollo Health and Ufestyle Ltd Organizing the unorganized • Patho

  9. Slide 9: India's Largest Omni-channel Healthcare Platform

    AHL| India’s Largest Omni-channel Healthcare Platform Apollo HealthCo Ltd • I • Apollo 24|7 Apollo Telehealth* Offline Pharmacy Distribution (n hi Manish • • Provides comprehensive remote • India’s largest Organized Pharmacy Platform with Alw.tya c.aung about your hc~Uh we arc here to holp you! heal

  10. Slide 10: Clinical Updates and New Initiatives

    Clinical Updates and New Initiatives • Apollo Hospitals crossed the milestone of 25,000+ cumulative transplants, with Hyderabad playing a pivotal role—reaffirming Apollo’s leadership in complex, high-acuity care and transplant innovation. • Indraprastha Apollo Hospitals, Delhi performed a landmark d

  11. Slide 11: Consolidated Financials

    • Consolidated Financials Consolidated Financials © 2025 Apollo Hospitals Enterprise Ltd, All Rights Reserved 10

  12. Slide 12: Consolidated Financials Q4FY25

    Consolidated Financials Q4FY25 (` mio) Digital Health Healthcare Diagnostics & Overall Consolidated Revenue grew by 13% to ` 55,922 mio. ` Mio & Pharmacy Consol Services Retail Health Distribution Total Revenues 28,219 3,940 23,763 55,922 EBITDA grew by 20% to ` 7,698 mio. EBITDA (Pre 24|7 Cost) 6,8

  13. Slide 13: Consolidated Financials FY25

    Consolidated Financials FY25 (` mio) Digital Health & Overall Consolidated Revenue grew by 14% to ` 217,940 mio. Healthcare Diagnostics & ` Mio Pharmacy Consol Services Retail Health EBITDA grew by 26% to ` 30,219 mio. Distribution Total Revenues 111,475 15,535 90,930 217,940 EBITDA (Pre 24|7 Cost)

  14. Slide 14: Healthcare Services Hospitals

    • Healthcare Services Hospitals © 2025 Apollo Hospitals Enterprise Ltd, All Rights Reserved 13

  15. Slide 15: Healthcare Services Financials

    Healthcare Services Financials (` mio) ` Mio Q4FY25 Q4FY24 YoY FY25 FY24 YoY No of Hospitals 45 45 45 45 Healthcare Services Revenue grew by 10% in Q4FY25 Operating beds 8,025 7,945 1% 8,025 7,945 1% (Inpatient Volume grew by 4% ; Price & case mix of 6%) Occupancy 67% 65% 68% 65% IP Discharges 146,4

  16. Slide 16: Inpatients Revenue Mix FY25

    Inpatients Revenue Mix FY25 Paed IPS Transplts Uro PSU & Govt 3% 3% Cardio 5% Nephro 3% 19% 10% 4% Self Pay Obs&Gynac 4% Gen Surg 4% 41% 7% Inpatient Inpatient Others Specialty Mix Payor Mix 17% Onco* 9% Internal Med 10% 44% Gastro 6% 10% Neuro Insurance Ortho * Oncology includes Radiotherapy and Ch

  17. Slide 17: Healthcare Services: Operational Snapshot

    Healthcare Services : Operational Snapshot Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi FY25 Metros Non Metros Non Metros (includes Tier1 & Tier2 cities) Ahmedabad, Bhubaneshwar, Lucknow, Operating Indore, Guwahati, Madurai, Trichy, 4,578 3,447 Nellore,Vizag, Kakinada, Mysore, Na

  18. Slide 18: Tamil Nadu Region

    Tamil Nadu Region Metro:- Chennai ; Non Metro:- Madurai, Karur, Karaikudi, Trichy and Nellore Nellore Nellore Chennai Tamil Nadu Region Q4FY25 Q4FY24 YoY FY25 FY24 YoY Operating Beds 2,068 2,029 1.9% 2,068 2,029 1.9% Bed Occupancy Rate (%) 65% 63% 64% 63% Trichy Inpatient volume 37,308 37,000 0.8% 1

  19. Slide 19: AP, Telangana Region

    AP, Telangana Region Metro:- Hyderabad; Non Metro:- Karimnagar, Vizag and Kakinada Vishakhapatnam AP, Telangana Region Q4FY25 Q4FY24 YoY FY25 FY24 YoY Operating Beds 1,240 1,270 -2.4% 1,240 1,270 -2.4% Bed Occupancy Rate (%) 64% 56% 67% 57% Inpatient volume 20,847 18,933 10.1% 86,689 77,036 12.5% Ka

  20. Slide 20: Karnataka Region

    Karnataka Region Metro:- Bangalore; Non Metro:- Mysore Karnataka Region Q4FY25 Q4FY24 YoY FY25 FY24 YoY Operating Beds 772 748 3.2% 772 748 3.2% Bed Occupancy Rate (%) 70% 68% 74% 67% Inpatient volume 16,278 16,019 1.6% 69,499 64,241 8.2% Outpatient volume (1) 68,475 55,779 22.8% 272,794 210,037 29.

  21. Slide 21: Eastern Region

    Eastern Region Metro:- Kolkata; Non Metro:- Guwahati, Bhubaneshwar, Bilaspur and Rourkela Eastern Region Q4FY25 Q4FY24 YoY FY25 FY24 YoY Guwahati Operating Beds 1,867 1,820 2.6% 1,867 1,820 2.6% Bed Occupancy Rate (%) 73% 74% 75% 74% Inpatient volume 32,885 31,730 3.6% 134,041 125,209 7.1% Outpatien

  22. Slide 22: Western Region

    Western Region Metro:- Navi Mumbai; Non Metro:- Nashik and Ahmedabad Western Region Q4FY25 Q4FY24 YoY FY25 FY24 YoY Ahmedabad Operating Beds 876 861 1.7% 876 861 1.7% Bed Occupancy Rate (%) 56% 57% 58% 55% Inpatient volume 13,508 12,698 6.4% 53,703 50,221 6.9% Nashik Outpatient volume (1) 54,305 52,

  23. Slide 23: Northern Region

    Northern Region Metro:- Delhi; Non Metro:- Lucknow and Indore Delhi Northern Region Q4FY25 Q4FY24 YoY FY25 FY24 YoY Lucknow Operating Beds 1,202 1,217 -1.2% 1,202 1,217 -1.2% Bed Occupancy Rate (%) 70% 66% 73% 68% Inpatient volume 25,608 24,192 5.9% 107,650 98,827 8.9% (1) Outpatient volume 90,156 6

  24. Slide 24: Healthcare Services: Expansion Plan

    Healthcare Services: Expansion Plan Balance Total Census Project Cost Location Nature Project Cost Beds Beds (in Crs) (in Crs) Expected commissioning : FY26 Royal Mudhol, Pune Hospital Asset Acquisition 400 325 ₹ 630 ₹ 260 Sonarpur, Kolkata Hospital Asset Acquisition 270 220 ₹ 310 ₹ 130 Gachibowli,

  25. Slide 25: Diagnostics & Retail Health: Apollo Health & Lifestyle Ltd

    • Diagnostics & Retail Health Apollo Health & Lifestyle Ltd © 2025 Apollo Hospitals Enterprise Ltd, All Rights Reserved 24

  26. Slide 26: Executive Summary

    Executive Summary Primary Care Diagnostics Specialty Care J.A IIO o·13I ~SIS il),A ~.A ~lo #'\po .' Clinics Apollo Sugar ® Clinics Apollo DIAGNOSTICS ® il)A Apollo Soectra IHOSPITALS Specialists in Surgery e Cradle &Children's Hospital ltollo Fertility  Core revenues of Primary Care grew by  Welln

  27. Slide 27: AHLL Financials Q4FY25

    AHLL Financials Q4FY25 (` mio) Corporate / Primary Care Diagnostics Specialty Care Intra Group AHLL AHLL revenue & EBITDA grew by 11% & Revenue 1,150 1,278 1,708 -197 3,940 32% YoY in Q4’FY25 respectively; EBITDA 268 116 197 -109 472 primarily driven by network maturity Q4FY25 margin (%) 23.3% 9.1%

  28. Slide 28: AHLL Financials FY25

    AHLL Financials FY25 (` mio) AHLL revenue & EBITDA grew by 14% & 32% YoY in FY25 respectively; primarily Corporate / driven by network maturity across key Primary Care Diagnostics Specialty Care AHLL Intra Group segments Revenue 4,277 5,000 6,965 -706 15,535 EBITDA 844 523 773 -602 1,538 Primary car

  29. Slide 29: Diagnostics: Key Parameters

    Diagnostics : Key Parameters Gross Revenue (INR Mn) EBITDA (INR Mn)1 Operational footprint (as of March 31, 2025) 14% 13% ~330+ 9% 10% ~330+ 9% Cities Cities presence 1,345 168 181 presence 1,212 1,278 1,169 1,164 110 116 116 1 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25

  30. Slide 30: Digital Health & Pharmacy Distribution: Apollo HealthCo

    Digital Health & Pharmacy • Distribution Apollo HealthCo © 2025 Apollo Hospitals Enterprise Ltd, All Rights Reserved 29

  31. Slide 31: India's Largest Omni-Channel Healthcare Platform

    India’s Largest Omni-Channel Healthcare Platform Apollo 247 Digital Platform Apollo Pharmacy Platform 6,626 Stores ~16.2% Omni Private ~40 Mn+ Registrations n hi Manish • Added - FY 607 label / generics Chandigarh: 5 mix ,r; Book Apollo Doctor Appoinlmc,nl ,>JI Himachal Pradesh: 6 Closed –FY 11 - FY

  32. Slide 32: Apollo HealthCo Financials Q4FY25

    Apollo HealthCo Financials Q4FY25 (` mio) Online Healthco (Q4’ FY25 vs Q4’ FY24): Offline Pharmacy Total ` Mio Pharmacy Distribution & HealthCo o 17% growth in revenue in Q4’ FY25 vs Q4’ FY24 Distribution Apollo 247 Total Revenues 20,844 2,919 23,763 o PAT positive in Q4’FY25 (Rs. 88 Mn) vs loss of

  33. Slide 33: Apollo HealthCo Financials FY25

    Apollo HealthCo Financials FY25 (` mio) Online Offline Pharmacy Total Healthco (FY 25 vs FY24); ` Mio Pharmacy Distribution & HealthCo Distribution Apollo 247 o 16% growth in revenue in FY25 vs FY24 Total Revenues 80,143 10,787 90,930 o PAT positive in FY25 Rs. 469 Mn vs loss of (Rs.1,957 Mn) in EBI

  34. Slide 34: Apollo HealthCo: Advent Investment - Tranche 1&2 completed

    Apollo HealthCo : Advent Investment - Tranche 1&2 of INR 2,475 crs completed • Apollo Healthco Limited (“AHL”) raised equity capital of INR 2,475 Crs (USD 300 Mn) from Advent International (“Advent”)1, one of the largest global private equity investors with an AUM of over USD 94 Bn. Tranche 1 of INR

  35. Slide 35: Synergetic Benefit of the Keimed Merger

    Synergetic Benefit of the Keimed Merger Becoming India’s Leading Healthcare Provider 1 Leading Pharma End-to-end, Patient retention Distributor seamless, omnichannel User satisfaction + business model of pharmacy Cross selling Growing Omni distribution with a Apollo Channel Platform fast-growing dig

  36. Slide 36: Proposed Transaction Structure and Steps (1/2)

    Proposed Transaction Structure and Steps (1/2) Post Advent Tranche 1 Investment Post Advent Tranche 2 Investment Pre-Transaction (T) (T+12 Months) AHEL ESOP AHEL Advent ESOP AHEL Advent ESOP 95% 5*% 83.1% 12.5%1 4.4% 79.0% 16.9% 4.1% 2% 11.2% AHL AHL Keimed AHL Keimed Tranche 1 Tranche 2 • Advent in

  37. Slide 37: Proposed Transaction Structure and Steps (2/2)

    Proposed Transaction Structure and Steps (2/2) Launch of Merger Process Post Merger (T+15 Months) (T+30 Months) Keimed AHEL Promoters Keimed 61.5% AHEL 79.0% Shareholders Other minority Advent ESOP FHPL partners 59.2%** 25.7%# Min Max 16.9% 4.1% 16.1% 11.2% Advent ESOP 11.2%* 12.1%+ 3.0% AHL Keimed

  38. Slide 38: Combined Financials Metrix Snapshot FY25

    Combined Financials Metrix| Snapshot FY25 (` mio) FY24 Offline Pharma Online Pharma Combined Combined Distribution Total Healthco Keimed Combined Distribution+247 FY25 Q4’FY25 Revenue 137,701 80,143 10,787 90,930 130,062 163,772 42,455 EBITDA,Pre 9,614 5,908 1,373 7,282 3,898 11,180 2,801 INDAS EBIT

  39. Slide 39: Annexure

    • Annexure © 2025 Apollo Hospitals Enterprise Ltd, All Rights Reserved 38

  40. Slide 40: Basis of Consolidation

    Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services Platform 100.00% Tondiarpet - Chennai Chennai A

  41. Slide 41: IND AS 116: Impact on P&L and Balance Sheet – FY25

    IND AS - 116 : Impact on P&L and Balance Sheet –FY25 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use Asset 13,285 Revenue Right of use Asset 24,653 Revenue as of Other expenses 1,102 as of Other expenses 2,537

  42. Slide 42: Thank you !!

    Thank you !! 41

Apollo Hospitals Enterprise — Q4 FY25 Earnings Presentation on 6ix